WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003074529) iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/074529    International Application No.:    PCT/IB2003/000740
Publication Date: 12.09.2003 International Filing Date: 17.02.2003
Chapter 2 Demand Filed:    27.03.2003    
IPC:
C07D 495/04 (2006.01)
Applicants: PFIZER INC. [US/US]; 235 East 42nd Street, New York, NY 10017 (US) (For All Designated States Except US).
KANIA, Robert, Steven [US/US]; (US) (For US Only).
ROMINES, William, Henry III [US/US]; (US) (For US Only).
CRIPPS, Stephan, James [US/US]; (US) (For US Only).
HE, Mingying [CN/US]; (US) (For US Only).
LOU, Jihong [CN/US]; (US) (For US Only).
ZHOU, Ru [CN/US]; (US) (For US Only)
Inventors: KANIA, Robert, Steven; (US).
ROMINES, William, Henry III; (US).
CRIPPS, Stephan, James; (US).
HE, Mingying; (US).
LOU, Jihong; (US).
ZHOU, Ru; (US)
Agent: LUMB, J., Trevor; Pfizer Inc., 201 Tabor Road, Morris Plains, NJ 07950 (US)
Priority Data:
60/360,952 01.03.2002 US
Title (EN) iNDOLYL-UREA DERIVATIVES OF THIENOPYRIDINES USEFUL AS ANTI-ANGIOGENIC AGENTS
(FR) DERIVES INDOLYL-UREE DE THIENOPYRIDINES UTILISES COMME AGENTS ANTIANGIOGENIQUES, ET LEURS METHODES D'UTILISATION
Abstract: front page image
(EN)The invention relates to compounds represented by the formula FI and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein X, R1 and R11 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of treating hyperproliferative disorders in a mammal by administering the compounds of formula I.
(FR)L'invention concerne des composés représentés par la formule générale (I), des promédicaments de ces composés, ainsi que des sels de qualité pharmaceutique ou des solvates de ces composés ou de ces promédicaments. Dans cette formule générale (I), X, R1 et R11 désignent des éléments définis dans le descriptif de la présente demande. L'invention concerne également des compositions pharmaceutiques renfermant les composés représentés par la formule générale (I), ainsi que des méthodes destinées au traitement de troubles hyperprolifératifs chez un mammifère, consistant à administrer lesdits composés.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)